🇺🇸 FDA
Patent

US 9687527

Stable glucagon formulations for the treatment of hypoglycemia

granted A61KA61K38/26A61K47/02

Quick answer

US patent 9687527 (Stable glucagon formulations for the treatment of hypoglycemia) held by The Regents of the University of Colorado, a Body Corporate expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Jun 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K38/26, A61K47/02, A61K47/12, A61K47/183